SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-065453
Filing Date
2024-03-12
Accepted
2024-03-12 08:43:01
Documents
15
Period of Report
2024-03-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d803206d8k.htm   iXBRL 8-K 26989
2 EX-3.1 d803206dex31.htm EX-3.1 4192
  Complete submission text file 0001193125-24-065453.txt   165880

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA implq-20240308.xsd EX-101.SCH 2499
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE implq-20240308_lab.xml EX-101.LAB 20353
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE implq-20240308_pre.xml EX-101.PRE 12627
17 EXTRACTED XBRL INSTANCE DOCUMENT d803206d8k_htm.xml XML 4298
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IPI Legacy Liquidation Co (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 8-K | Act: 34 | File No.: 001-40353 | Film No.: 24740338
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)